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Abstract 
Background: Foamy viruses (FVs) of the Spumaretrovirinae subfamily are distinct retroviruses, with many features of 
their molecular biology and replication strategy clearly different from those of the Orthoretroviruses, such as human 
immunodeficiency, murine leukemia, and human T cell lymphotropic viruses. The FV Gag N-terminal region is respon-
sible for capsid formation and particle budding via interaction with Env. However, the critical residues or motifs in this 
region and their functional interaction are currently ill-defined, especially in non-primate FVs.
Results: Mutagenesis of N-terminal Gag residues of feline FV (FFV) reveals key residues essential for either capsid 
assembly and/or viral budding via interaction with the FFV Env leader protein (Elp). In an in vitro Gag–Elp interaction 
screen, Gag mutations abolishing particle assembly also interfered with Elp binding, indicating that Gag assembly is 
a prerequisite for this highly specific interaction. Gradient sedimentation analyses of cytosolic proteins indicate that 
wild-type Gag is mostly assembled into virus capsids. Moreover, proteolytic processing of Gag correlates with capsid 
assembly and is mostly, if not completely, independent from particle budding. In addition, Gag processing correlates 
with the presence of packaging-competent FFV genomic RNA suggesting that Pol encapsidation via genomic RNA 
is a prerequisite for Gag processing. Though an appended heterogeneous myristoylation signal rescues Gag particle 
budding of mutants unable to form capsids or defective in interacting with Elp, it fails to generate infectious particles 
that co-package Pol, as evidenced by a lack of Gag processing.
Conclusions: Changes in proteolytic Gag processing, intracellular capsid assembly, particle budding and infectivity 
of defined N-terminal Gag mutants highlight their essential, distinct and only partially overlapping roles during viral 
assembly and budding. Discussion of these findings will be based on a recent model developed for Gag–Elp interac-
tions in prototype FV.
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Background
Retroviruses use two different major assembly and bud-
ding pathways. In most Orthoretroviruses including 
human immunodeficiency viruses (HIV), fully assem-
bled capsids cannot be detected in the cytoplasm, since 
assembly of Gag and Gag-Pol take place at the plasma 
membrane at the site of budding [1, 2]. This type of bud-
ding pathway is used by type C retroviruses, such as 
avian sarcoma leukosis virus, murine leukemia virus, 
HIV and other lentiviruses [3–5]. In the second path-
way, Gag assembles into premature capsids within the 
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cytoplasm, which are then transported to the plasma 
membrane and acquire an envelope upon budding. Type 
B/D retroviruses, such as mouse mammary tumor virus 
and Mason-Pfizer monkey virus, are known to use this 
budding pathway [6–9].
Foamy viruses (FVs) have many unique features that 
set them apart from most Orthoretroviruses [10]. While 
Gag and Env structure, processing and the mechanisms 
driving particle release are FV-specific, FV capsid assem-
bly resembles, at least in some aspects, that of type B/D 
retroviruses since FV capsid assembly also occurs at 
the pericentriolar site, around the microtubule organiz-
ing center (MTOC) [7, 11, 12]. Secondly, FV Gag is not 
N-terminally myristoylated like in most Orthoretrovi-
ruses. Thirdly, FV Gag particle budding relies absolutely 
on the expression of the cognate Env [13, 14]. Thus FV 
cannot be pseudotyped by foreign glycoproteins, such as 
VSV-G, since it does not allow the critical Gag-Env inter-
actions needed for release [10]. Finally and unique among 
retroviruses, Gag in released FV particles is not pro-
cessed into the mature matrix, capsid and nucleocapsid 
domains MA, CA, and NC but instead remains largely 
unprocessed except for a C-terminal cleavage event that 
is required for particle infectivity [15].
The FV Elp subunit of Env is an abundant and stable 
component of viral particles, with its N-terminal cyto-
solic region interacting with the Gag MA layer during 
budding [13, 14, 16, 17]. Two conserved tryptophan resi-
dues were identified as essential for specific interactions 
between Env and Gag, allowing particle budding [13, 14]. 
Biophysical analyses of the capsid structure by cryoelec-
tron microscopy and surface plasmon resonance suggest 
that direct and specific binding between Elp and N-ter-
minal residues of Gag is essential for particle release [13, 
14, 16]. Maturation of assembled viral particles requires 
the activity of Pol, which is expressed independent of Gag 
via a spiced, sub-genomic transcript [18, 19]. The FV Pol 
precursor is auto-catalytically processed by the protease 
(PR) into only two subunits. The larger subunit confers 
protease/reverse transcriptase/RNase H (PR-RT-RN) 
enzymatic activities, while the smaller subunit has inte-
grase (IN) activity [15, 20]. Genomic RNA is required for 
efficient Pol incorporation into viral particles [21, 22].
A number of functional domains or motifs in proto-
type/primate FV (PFV) Gag have been proposed by bio-
informatics or functionally characterized. Four predicted 
coiled-coil (CC) motifs may exist in PFV Gag. The CC1 
motif is located at the extreme N-terminus (residues 
4–19). Studies indicated that this region is responsible for 
interaction with Env [23, 24]. The CC2 motif (133–146) 
is also located at the N-terminus and may be crucial for 
Gag–Gag interaction during viral assembly, similar to 
those mediated in MA domains of the Orthoretroviruses 
[25]. The CC3 motif (161–174) is mainly involved in 
interaction between Gag molecules for capsid formation 
and the light chains of dynein motor protein complexes, 
which facilitate viral particle transport to the MTOC 
[26]. The biological function of the CC4 motif, which lies 
upstream of three glycine-arginine (GR) rich boxes in 
PFV responsible for genome packaging, nuclear localiza-
tion and reverse transcription [27–29], has not yet been 
characterized. In other FVs, a less defined GR-rich region 
replaces these boxes [30]. Close to the N-terminus of 
PFV Gag, a cytoplasmic targeting and retention signal 
(CTRS) homologous to that of the B/D morphotype ret-
roviruses is responsible for directing Gag to the MTOC, 
the cytoplasmic capsid assembly site [11, 12]. The CTRS 
domain consists of approximately 16 amino acids cen-
tered around a critical arginine (R) at position 50 in PFV 
Gag [11]. Mutation of this central Arg results in a block in 
capsid assembly and viral budding, even in the presence 
of Env [11]. Finally, an efficiently utilized cleavage site of 
the viral PR lies close to the C-terminus of Gag [15]. Due 
to the intracellular capsid assembly, budding of FV parti-
cles into intracellular membrane compartments and their 
relatively inefficient release, Gag processing can already 
be observed in cell-associated Gag and Pol proteins [15].
Phylogenetic analyses indicate that PFV Gag is dis-
tantly related to the non-primate FVs, such as feline, 
bovine, and equine FVs (FFV, BFV and EFV, respectively) 
[31]. Moreover, many predicted structural domains or 
motifs in PFV Gag are different compared to the non-
primate FVs. For instance, the GR boxes of primate FVs 
are replaced by less defined arrays of glycine and argi-
nine residues and a 100–130 amino acid insertion is pre-
sent in PFV and simian FV Gags compared to FFV, EFV 
and BFV starting at around Gag residue 160 [30]. For a 
deeper understanding of the function of FV Gag during 
viral replication, our studies were extended to FFV by 
focusing on the characterization of the FFV Gag N-ter-
minal residues essential for viral assembly and budding. 
We identify key determinants harbored within the N-ter-
minus of FFV Gag responsible for capsid assembly, bud-
ding and interaction with Env and Elp. We also analyzed 
the influence of Pol and genomic RNA on Gag process-
ing, particle assembly and release.
Results
N‑terminal deletions of FFV Gag interfere with particle 
budding
To analyze whether the N terminus of FFV Gag is 
responsible for particle budding, increasing amino acid 
deletions together with a cloning-associated Gag-E4A 
exchange [32], were introduced into gag in the wild-type 
(wt) proviral clone pCF-7 (Fig. 1a). 293T cells transfected 
with mutant and wt FFV genomes were analyzed 2 days 
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post-transfection (p.t.). Mutant and wt Gag proteins were 
expressed at comparable levels in the cells. However, FV-
specific Gag processing at the C-terminus was impaired 
in E4A∆5-11. Expression of the Env gp130Env precur-
sor was comparable for all clones, while levels of the Pol 
precursor and the PR-RT-RNaseH domain (p127Pol and 
p65Pol, respectively) varied among the clones (Fig. 1b, left 
panel). Cleared culture supernatants were sedimented 
through 20 % sucrose to detect particle release. The bud-
ding capacity of E4A∆5 Gag particles containing gp48™ 
(TM) and p65Pol was similar to that of wt Gag (Fig.  1b, 
right panel, lanes 1 and 5). However, deletion of two or 
more amino acids displayed low-level Env-only subviral 
particle budding (Fig. 1b, left panel, lanes 2–4) [33, 34]. 
Release of Gag- and Pol-containing virions or VLPs was 
undetectable. In line with these data, only mutant E4A∆5 
maintained wt infectivity; all other mutants were non-
infectious (data not shown). Taken together, these data 
substantiate the hypothesis that the integrity of N-termi-
nal Gag sequences is required for full biological activity 
of Gag and the assembly and release of wt FV particles.
N‑terminal Gag motifs essential for FFV particle release 
and infectivity
To identify Gag motifs essential for viral particle forma-
tion and budding, FFV Gag residues 5-44 in pCF-7 were 
Fig. 1 Phenotype of N-terminal Gag deletion mutants. a Schematic of the FFV N-terminal Gag deletion mutants. Four Gag mutants (E4AΔ5, 
E4AΔ7, E4AΔ9, E4AΔ11) were constructed based on the proviral clone pCF-7. b 293T cells were transfected in 10 cm dishes with 8 µg of proviral 
pCF-7-based Gag mutants (lanes 1–4), the wild-type parental pCF-7 (lane 5) or pcDNA (lane 6). Aliquots of cell lysates and VLPs in supernatants were 
analyzed by SDS-PAGE. Positions of Gag p48 and p52, full-length Env precursor gp130Env, mature processed Env gp48™, Pol precursor p127Pol and 
PR-RT-RN domain p65Pol are marked
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mutated in blocks of five by alanine scanning mutagenesis 
(Fig. 2a). As above, protein expression in transfected cells, 
infectivity and particle release were analyzed 2  days p.t. 
Intracellular expression of FFV Env and Pol (Fig. 2b, lower 
panels) was not affected. However, C-terminal process-
ing of Gag was abrogated (clones mAVRFT, mGGPWG 
and mPGDRW) or strongly impaired (clones mLQQLY 
and mHGDII). Gag processing in mutants mLNPLQ, 
mINNGL and mQPNPG was similar to that of wt.
The budding efficacy of the proviral mutants mINNGL 
and mQPNPG, as determined by Gag, Pol and Env 
detection in particulate supernatants after sucrose 
cushion centrifugation, was similar to the wt (Fig.  2b, 
upper panels). Clone mLNPLQ displayed reproducibly 
lower levels of particle release. Particle release by Gag 
mutants mLQQLY, mHGDII, mAVRFT, mGGPWD and 
mPGDRW was undetectable in culture supernatants 
(Fig. 2b, lanes 2 and 5–8). Budding of mutants was fully 
reflected by their infectivity, as measured by titration on 
FeFab cells. Budding-competent mutants mINNGL and 
mQPNPG retained wt infectivity, while mLNPLQ with 
impaired budding showed a more than 103-fold reduc-
tion in infectivity (Fig.  2c). Budding-incompetent Gag 
mutants mLQQLY, mHGDII, mAVRFT, mGGPWG and 
mPGDRW were completely non-infectious. Additionally, 
cells expressing proviral Gag mutants mLQQLY, mHG-
DII, mAVRFT, mGGPWG and mPGDRW did not exhibit 
cell fusion activity whereas cells expressing mLNPLQ, 
mINNGL, mQPNPG and wt FFV Gag proteins dis-
played the characteristic syncytia indicated by large and 
GFP-positive cell fusions that are a hallmark for wt FFV-
infected cells (Additional file 1: Figure S1A).
The different budding, proteolytic Gag processing, 
syncytia formation, and infectivity phenotypes of these 
N-terminal proviral Gag mutants imply multiple func-
tions for N-terminal residues during capsid assembly 
Fig. 2 Budding of defined FFV five-alanine Gag mutants. a Five-alanine scanning mutagenesis at the N-terminus of FFV Gag. Eight Gag mutants 
(mLNPLQ, mLQQLY, mINNGL, mQPNPG, mHGDII, mAVRFT, mGGPWG and mPGDRW) were constructed based on the proviral clone pCF-7 or the Gag 
expression plasmid pBC-Gag-oPRE. m indicates a replacement of the original sequence with five alanines (underlined). b 293T cells were trans-
fected in 10 cm dishes with 8 µg of each proviral pCF-7-based Gag mutant (mLNPLQ, mLQQLY, mINNGL, mQPNPG, mHGDII, mAVRFT, mGGPWG or 
mPGDRW) (lanes 1–8), pCF-7 (lane 9) or pcDNA (lane 10). Aliquots of cell lysates and VLPs in supernatants were analyzed by SDS-PAGE. Positions of 
Gag p48 and p52, full-length Env precursor gp130Env; mature processed Env gp48™, Pol precursor p127Pol and PR-RT-RN domain p65Pol are marked. 
c Two days p.t., released particles were titrated onto FeFab cells. Mean titers of three independent experiments are given. Error bars represent the 
standard deviation
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and maturation, Env interaction and particle release. In 
293T cells, syncytia formation is greatly enhanced upon 
co-expression of wt Gag, possibly due to Gag-mediated 
surface targeting or capsid-induced Env clustering 
(YL and ML, unpublished observations). Furthermore, 
while mutants mLQQLY and mHGDII are defective 
in syncytia formation, particle release and infectiv-
ity, mutants mAVRFT, mGGPWG and mPGDRW are 
additionally defective in intracellular Gag processing. 
Based on these observations and published data and 
concepts for FV cytosolic capsid assembly, Gag process-
ing and Env-dependent particle release [9], it is likely 
that Gag assembly is completely abrogated in mutants 
mAVRFT, mGGPWG and mPGDRW as indicated by 
the absence of Gag processing that is assumed to be 
dependent on capsid assembly. Since at least a certain 
degree of Gag processing occurs in mutants mLQQLY 
and mHGDII, capsid assembly and Gag processing may 
be still functional and these mutants are only deficient 
in particle release. The rest of the mutants displayed a 
wt phenotype or only a clearly reduced viral infectivity 
(mLNPLQ).
Mutations of Gag residues 30–44 disrupt particle assembly
To study capsid assembly of wt and mutant Gag pro-
teins, the corresponding proviruses were transfected 
into 293T cells. Cytosolic fractions were harvested 2 days 
p.t. using a method established for PFV but employing 
a tenfold reduced concentration of a non-ionic deter-
gent [11]. Sucrose gradient sedimentation was subse-
quently used to determine whether mutant Gag proteins 
have the capacity to assemble into cytosolic FV capsids 
[11]. wt FFV capsids accumulated mainly in fraction 5 
(Fig. 3a, top panel, fraction S5). The absence of Gag pro-
teins in the top fraction 1 (S1) suggests that most, if not 
all, cytosolic Gag proteins entered the gradient as higher 
molecular forms; free, non-assembled wt Gag was rare. 
Faint bands in fraction 2 and 3 (S2, S3) were interpreted 
as sub-capsid Gag assemblies, such as capsomeres with 
lower sedimentation coefficients corresponding to their 
presence in 10–30 % sucrose.
The infectious and budding-competent proviral Gag 
mutants mLNPLQ, mINNGL and mQPNPG and bud-
ding-incompetent mutants mLQQLY and mHGDII, 
which retained Gag processing, did not show any obvious 
Fig. 3 Intracellular capsid assembly of FFV Gag mutants determined by sedimentation and transmission electron microscopy analyses. a 293T 
cells were transfected in 10 cm dishes with 8 µg of proviral pCF-7-based Gag mutants (mLNPLQ, mLQQLY, mINNGL, mQPNPG, mHGDII, mAVRFT, 
mGGPWG or mPGDRW) or the parental provirus pCF-7. Two days p.t., cytoplasmic extracts were prepared and used for sucrose gradient sedimenta-
tion. Each six fractions (S1–S6) were collected from the top of the gradient and analyzed by immunoblotting. Positions of FFV Gag p48 and p52 are 
marked. b Intracellular capsid assembly of wt Gag and Gag mutants mLQQLY and mHGDII were visualized by transmission electron microscopy of 
transfected and fixed 293T cells. Transmission electron micrographs show representative thin sections of 293T cells transiently transfected with pCF-
7-based plasmids expressing mLQQLY, mHGDII or wt Gag. Capsids are marked by black arrows. Scale bars are 500 nm in length
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phenotypic changes in Gag distribution compared to wt 
Gag. As expected, high amounts of full-length and pro-
cessed Gag were detected in the more dense capsid frac-
tion S5. Low to moderate amounts of less defined Gag 
assemblies were detected in fractions S2–S4. In stark 
contrast, the more distal Gag mutants mAVRFT, mGG-
PWG and mPGDRW, with mutations between Gag 
residues 30–44, exhibited unprocessed Gag proteins 
throughout fractions S2–S4/S5, indicating unspecific Gag 
aggregation rather than a major and well-defined capsid 
assembly product. In line with studies on the assembly-
relevant R50 residue in the PFV CTRS [11], alanine scan-
ning mutagenesis of the FFV counterpart Gag R43 and 
its flanking residues (mPGDRW) inhibited FFV capsid 
assembly.
Intracellular capsid assembly of the wt FFV provi-
rus and mutants mLQQLY, mHGDII and mAVRTF was 
examined by TEM of correspondingly transfected 293T 
cells. In wt FFV-transfected cells, intracellularly assem-
bled capsids were mainly detected at the MTOC, with 
particle budding and release events at the plasma mem-
brane (Fig.  3b, lower panels). Mutants mLQQLY and 
mHGDII formed capsid structures in the cytoplasm 
(Fig. 3b) but no particle released events were observed, as 
expected because of their budding-deficient phenotype 
(Fig.  2b). The size and morphology of the capsids were 
indistinguishable from wt FFV, suggesting that these 
mutations did not alter the gross viral structure. In cells 
transfected with mutant mAVRFT, assembled capsids 
were not detectable (data not shown).
Mapping of N‑terminal FFV Gag residues critical for capsid 
assembly, budding and infectivity
Based on the alanine scanning mutagenesis of FFV Gag 
mutants mLQQLY, mHGDII, mAVRFT, mGGPWG and 
mPGDRW (Figs. 2, 3), the presence of conserved residues 
in the N-terminus of FV Gag (Fig. 4a) and published data 
for PFV [9], individual amino acid replacements in Gag 
were engineered, generating single amino acid proviral 
Gag mutants pCF-7-L10A, Q11A, Q12A, L13A, Y14A, 
H25A, G26A, D27A, I28A, I29A, R32A, G36A, W38A, 
G39A, R43A, L51A and D53A (Fig. 4a).
In 293T cells transfected with these single amino acid 
substitution mutants, similar amounts of wt and mutated 
Gag, Env and Pol proteins were detected (Fig. 4b, bottom 
panel), suggesting that the mutations did not affect over-
all protein abundance. Importantly, Gag processing was 
absent in mutants G36A and R43A. In addition, the Gag 
mutants had different budding capacities. Mutants L10A, 
Q12A, L13A, Y14A, G26A, D27A, I28A, I29A, W38A, 
G39A and D53A exhibited wt budding with processed 
Gag, Pol and Env in the particle fraction (Fig. 4b, top pan-
els). In contrast, mutant H25A had significantly impaired 
budding and Q11A, R32A, G36A, R43A and L51A did 
not bud at all (Fig. 4b, top panels). Viral titers of all bud-
ding-competent mutants were within a two-fold range 
of the wt, whereas the low-level budding mutant H25A 
retained only 10 % of wt infectivity (Fig. 4c). All infectious 
mutants induced syncytia in transfected cells (Additional 
file 1: Figure S1B). H25A partially lost cell fusion activity, 
as shown by the smaller syncytia size while Q11A, R32A, 
G36A, R43A and L51A also did not lead to any syncytia 
formation (Additional file 1: Figure S1B).
As anticipated, budding-deficient mutants (Q11A, 
R32A, G36A, R43A, and L51A) were not infectious 
(Fig. 4b, c). Strikingly, the budding-incompetent proviral 
Gag mutants Q11A, R32A and L51A displayed the dou-
ble bands indicative of Gag processing, while G36A and 
R43A completely lost proteolytic Gag processing (Fig. 4b, 
lanes 2, 13, 14, 17, and 18). The phenotype of alanine 
scanning mutant ∆HGDII is partly reflected by the H25A 
mutant. In contrast, mAVRFT displayed a complete loss 
of Gag functions (capsid formation, processing and bud-
ding), while mutagenesis of only the central arginine 
(R32) impaired particle release but not Gag processing 
and capsid assembly (see below). The distinct phenotypes 
of these N-terminal Gag mutants with respect to budding 
capacity, proteolytic processing and infectivity imply dif-
ferent roles for individual residues during assembly and 
budding.
Most Gag point mutations show intact capsid formation
Capsid assembly of budding-incompetent mutants 
Q11A, H25A, R32A, G36A, R43A, and L51A was com-
pared to mutant D53A and pCF-7 by sucrose gradient 
analyses of cytosolic extracts. The distribution of pro-
cessed and unprocessed Gag proteins of Q11A, H25A, 
R32A, G39A, and L51A was similar to that of the wt and 
wt-like D53A, with capsids sedimenting in fraction S5. 
In contrast, mutant G36A and R43A Gag proteins were 
evenly distributed throughout the gradients as a single 
unprocessed form of Gag, likely representing proteins 
aggregates and a lack of proper capsid assembly (Fig. 5). 
This clearly reflects the phenotype of the parental alanine 
scanning mutants mGGPWG and mPGDRW (Fig.  3a). 
The phenotype of FFV Gag R43A agrees with its corre-
sponding mutation in PFV Gag (R50) [11]. Importantly, 
the alanine scanning mutants and single amino acid 
replacements show a clear correlation of capsid assem-
bly and proteolytic Gag processing, indicating that cap-
sid assembly is a prerequisite for, among other things, Pol 
incorporation into the viral particle and PR activation. 
Thus, lack of capsid formation by mutants G36A and 
R43A may be responsible for downstream events, high-
lighting the complexity and interdependency of individ-
ual assembly steps.
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Assembly‑incompetent mutant Gag proteins localize to the 
nucleus
We next studied the subcellular localization of the 
different FFV Gag mutants in the proviral context. 
Transfection with all five alanine scanning mutants and 
controls was conducted using HeLa cells since they 
allow better visualization of subcellular structures com-
pared to 293T cells which have only a very narrow rim 
Fig. 4 Alanine point mutations of conserved N-terminal Gag residues abolish particle budding, infectivity and Gag processing. a Alignment of 
FV Gag sequences using ClustalW2 Multiple Sequence Alignment and identification of highly conserved residues. Sequences were obtained 
from SwissProt (FFV Gag, accession number O56860; EFV Gag, accession number Q9J4C8; BFV Gag, accession number O41893; SloEFV Gag from 
endogenous sloth FV [56]; PFV Gag, accession number P14349; SFVcpz Gag from chimpanzee, accession number Q87039; SFVora from orangu-
tan, accession number P27400; SFVmac Gag from macaque, accession number Q00071; SFVagm from African green monkey, accession number 
M74895). Highly conserved residues are marked in bold face letters and asterisks below the alignment. The proposed FFV Gag cytoplasmic targeting 
and retention signal (CTRS) is marked by a frame. Alanine point mutations of FFV Gag (L10A, Q11A, Q12A, L13A, Y14A, H25A, G26A, D27A, I28A, I29A, 
R32A, G36A, W38A, G39A, R43A, L51A and D53A, in red) were constructed using the proviral vector pCF-7 and the Gag expression clone pBC-Gag-
oRPE. b 293T cells were transfected in 10 cm dishes with 8 µg of plasmid encoding for proviral Gag mutants (L10A, Q11A, Q12A, L13A, Y14A, H25A, 
G26A, D27A, I28A, I29A, R32A, G36A, W38A, G39A, R43A, L51A and D53A, lanes 1–10 and 13–19, respectively), pCF-7 (lanes 11 and 20) or pcDNA (lanes 
12 and 21). Cell lysates and VLPs in supernatants were analyzed by SDS-PAGE. Positions of Gag p48 and p52, full-length Env precursor gp130Env, 
mature processed Env gp48™, Pol precursor p127Pol and PR-RT-RN domain p65Pol are marked. c Two days p.t., infectivity was assessed by titration 
onto FeFab cells. Mean relative titers of three independent titration experiments are shown. Error bars represent the standard deviation
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of cytosol around the nucleus. Cells were fixed 36 h p.t. 
using paraformaldehyde and processed for FFV Gag IFF 
using a MA-specific polyclonal antiserum. While all cap-
sid assembly-competent mutant Gag proteins showed 
mostly cytosolic and perinuclear subcellular localization 
similar to wt Gag, the assembly-deficient mutants mHG-
DII, mAVRFT, mGGPWG and mPGDRW were mainly 
or exclusively localized to the nucleus (Additional file 2: 
Figure S2). To refine these analyses, the single amino acid 
FFV Gag mutants Q11A, H25A, R32A, G36A, W38A, 
G39A, R43A, L51A, D53A, the wt provirus pCF7 and 
empty vector pcDNA were similarly analyzed, some of 
these IIFs are shown in Fig.  6. Overall, only FFV Gag 
mutants G36A and R43A displayed prominent nuclear 
localization of Gag (above 90 % of cells with nuclear Gag, 
with the remainder either cytosolic only or nuclear and 
cytosolic). All other capsid assembly-competent mutants, 
independent of their budding capacity or infectivity, were 
concentrated in the cytosol and around the nucleus, 
similar to wt Gag (56–75  % of cells with cytosolic Gag, 
0–14  % nuclear and 10–43  % in both compartments; 
Fig. 6 and data not shown). Importantly, none of the Gag 
mutants displayed gross protein aggregation.
Defined point mutations in Gag abolish the Gag–Elp 
interaction
Point mutations of conserved key residues in the N-ter-
minus of FFV Gag inhibit viral egress at different stages 
of viral replication, such as CTRS residues G36A and 
R43A, which block Gag assembly and processing and 
thereby particle budding. On the other hand, mutants 
R32A and L51A form intracellular capsids but are com-
pletely incapable of budding and are non-infectious. One 
plausible explanation for the latter phenotype is that 
these mutations interrupt the interaction of preformed 
capsids with Elp essential for membrane targeting and 
budding out of the cell.
The interaction of Elp and Gag in the budding-incom-
petent mutants was further investigated by pull-down 
assays using provirus-transfected 293T cells. For this 
purpose, 293T cells were transfected with plasmids 
encoding the wt (pCF-7) and proviral Gag mutants 
Q11A, R32A, G36A, W38A, G39A, R43A, L51A and 
D53A. Cell lysates (CL) were incubated with the bacteri-
ally expressed and purified cytosolic domain of Elp con-
taining the conserved Gag interaction domain [13, 14]. 
The budding-incompetent mutants Q11A, R32A, G36A, 
R43A and L51A (regardless of capsid formation capacity) 
were not precipitated by His-tagged Elp (Fig. 7), indicat-
ing that the Gag–Elp interaction was abolished and only 
assembled capsids are bound by Elp. An empty His-tag 
plasmid was used as negative control to precipitate Gag-
expressing 293T cell lysates, providing a non-relevant 
background binding in all cases. As expected, wt and wt-
like mutants W38A, G39A, D53A bound strongly to His-
tagged Elp and were pulled down from the cell lysates.
FFV capsid formation and Pol and genome encapsidation 
are required for Gag processing
The previous results indicate that Gag processing is 
tightly linked to capsid formation. We thus determined 
whether capsid formation and concomitant encapsi-
dation of the RNA genome together with the bound 
Pol protein is a prerequisite for Gag processing [21]. 
293T cells were co-transfected with subgenomic wt and 
mutant Gag Q11A, H25A, R32A, G36A, R43A and L51A 
Fig. 5 Gradient analysis of intracellular mutant Gag capsids. 293T cells were transfected in 10 cm dishes with 8 µg of pCF-7-Q11A, H25A, R32A, 
G36A, W38A, G39A, R43A, L51A, D53A or wild-type pCF-7. Two days p.t., cytoplasmic extracts of transfected 293T cells were prepared and used for 
sucrose gradient sedimentation. Each, six fractions (S1–S6, 700 μl) were collected from the top of the gradient and analyzed by immunoblotting. 
Positions of FFV Gag p48 and p52 are marked
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expression vectors, the Pol expression vector pMP-Pol-
oPRE and the Gag-deficient but packaging-competent 
FFV genome mATG. pcDNA was co-transfected instead 
of mATG to serve as a negative control (Fig.  8a) [35]. 
Although the vector genome may also direct Pol expres-
sion, both, the processed (p65Pol) and unprocessed Pol 
precursor (p127Pol) proteins were detected at similar 
levels in all samples (Fig. 8b). While wt and mutant Gag 
did not undergo PR processing in the absence of the FFV 
vector genome (Fig.  8b, lanes 1–7), capsid assembly-
competent Gag mutants Q11A, H25A, R32A and L51A 
processed Gag at a level similar to the wt in the presence 
of genomic RNA. As anticipated, only assembly-deficient 
Gag mutant proteins G36A and R43A remained com-
pletely unprocessed (Fig. 8b, lanes 8–14).
To further examine the role of viral RNA in Pol encap-
sidation and subsequent PR activity, we used a subviral 
system with RNA packaging-deficient mutant vector 
genomes as additional controls (Fig. 8a). 293T cells were 
co-transfected with pBC-Gag-oPRE, pMP-Pol-oPRE and 
pBC-Env encoding wt Gag, Pol and Env, together with 
pcDNA serving as the negative control or the packaging-
competent vector genome mATG or packaging-deficient 
genomes mATG-GC, mΔBBBB-GC and EO-GC. As 
shown in Fig.  8a, in all vectors the env-bel gene region 
of FFV is replaced by an Ubi-LacZ or Ubi-egfp reporter 
gene cassette. In mATG, only Gag expression is abro-
gated by Gag start codon mutagenesis while Pol can be 
still expressed. In contrast, mutagenesis of the major 5′ 
splice donor (suffix GC) abrogates genome packaging 
in mATG-GC. In the genomes mΔBBBB-GC, essen-
tial packaging sequences in pol are deleted while vector 
EO-GC carries an egfp instead of the lacZ reporter gene 
in a background similar to mATG-GC [35, 36]. Regular 
aliquots of cell lysates and VLPs were purified and ana-
lyzed by immunoblotting. Protein expression and particle 
release, as measured by detection of Gag in each fraction, 
were comparable for all co-transfections (Fig. 8c). Com-
pared to the RNA packaging-competent vector mATG 
(Fig.  8c, lane 1) inducing release of particle containing 
processed Gag and Pol, the packaging-deficient vector 
mATG-GC, mΔBBBB-GC and EO-GC and control plas-
mid pcDNA (Fig.  8c, lanes 2–5, respectively) resulted 
in the complete loss of Pol encapsidation and Gag pro-
cessing in released VLPs. As particle release was com-
parable for all co-transfections (Fig.  8c, lanes 1–5), we 
determined the RNA content in these released particles 
by qRT-PCR for the ubiquitin C promoter, contained in 
all vector genomes. A sharp decrease of the RNA con-
tent in the RNA packaging-deficient vectors (below 20 %) 
compared to that of the RNA packaging-competent vec-
tor was observed (Fig. 8d). Together, these data indicate 
that a packaging-competent genome is not required for 
capsid formation and that Pol expression alone is insuffi-
cient for Gag processing unless Pol is packaged into viral 
capsids via the viral genome containing the Pol encapsi-
dation signal [21].
Myr signal rescues capsid assembly and release 
but abolishes Gag processing and Pol encapsidation
To investigate the determinants essential for Gag pro-
cessing upon capsid assembly, we engineered FFV 
wt and Gag mutants mLQQLY (budding-deficient), 
mHGDII (budding-compromised) and mPGDRW 
(capsid assembly and Gag processing-deficient) with 
Fig. 6 Subcellular localization of wt and single-mutant FFV Gag 
proteins. HeLa cells were transfected with proviral pCF-7-based Gag 
mutants (R32A, G36A, G39A and R43A) and the parental provirus pCF-
7. pcDNA plasmid was used for transfection as negative control. At 
36 h p.t., cells were fixed and stained with a rabbit polyclonal antise-
rum generated against FFV Gag and Alexa-488-conjugated secondary 
antibody. Nuclei were stained with DAPI. Scale bars represent 50 µm
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a heterologous myr motif (src), known to rescue cap-
sid assembly by retargeting Gag from the MTOC to 
the plasma membrane and generating extracellular but 
non-infectious viral particles (Fig.  9a) [23, 32, 37]. In 
all tested myr-Gag genomes, particle budding was par-
tially restored, indicative of capsid assembly (Fig.  9b). 
However, Pol-mediated processing of wt and mutant 
myristoylated Gag was completely or dramatically (Src-
Gag) reduced in cellular lysates (Fig. 9b, lanes 5–8). This 
result is in line with the finding that Pol was not detect-
able in any of the particles containing myr-Gag (Fig. 9b, 
left hand panel), suggesting a failure to incorporate Pol 
into capsids. While reduced budding of the myr-Gag 
mutants (Src-mLQQLY, Src-mHGDII, Src-mPGDRW) 
may interfere with Pol detection in particles, Pol was 
also not detected in Src-Gag particles with only mod-
estly reduced budding. Analysis of cell lysates showed 
that Pol was expressed at comparable amounts by all 
constructs (Fig. 9b, right panel).
TEM studies of selected samples showed that in cells 
producing fully infectious wt FFV particles and cells 
expressing wt-Gag proteins, cytosolic capsids are abun-
dant (Fig.  9c, left and middle panels labelled FFV and 
Gag SVP) while myr-Gag assemblies were highly asso-
ciated with intracellular membranes or present in small 
membranous vesicles (Fig. 9c, right panels labelled Myr-
Gag-SVP). These particles were often irregular in shape 
and clearly distinct from Gag-only cytosolic capsids 
(Fig.  9c, middle panel labelled Gag SVP) or released wt 
particles. In addition to intracellular budding structures, 
myr-Gag accumulated at the plasma membrane, leading 
to the formation of budding structures and Gag SVPs. As 
expected, none of the wt or mutant myr-Gag genomes 
were infectious (data not shown).
To determine whether co-expression of myr-Gag 
interferes with wt FFV replication or, alternatively, even 
increases infectious viral particle release, 293T cells were 
co-transfected at different ratios (6:0, 5.5:0.5, 5:1, 4:2, 
Fig. 7 Mutations of specific residues in FFV Gag abolish its interaction with Elp. Cell lysates (CL) were prepared by transfecting 293T cells in 10 cm 
dishes with 8 µg of plasmid encoding Gag mutant (R32A, G36A, W38A, G39A, R43A, L51A or D53A) or wt Gag and used for protein pull down 
studies employing the recombinantly expressed cytosolic domain of Elp. Cells transfected with a plasmid encoding for wt Gag or an empty His-tag 
vector were used as positive or negative controls, respectively. The positions of FFV Gag p52 and His-tagged Elp are marked
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2:4, 0:6) of wt to myr-Gag-expressing proviral plasmids 
pCF-7 and Src-Gag. As a background control, Src-Gag 
was replaced by pcDNA. Co-transfection of pCF-7 and 
pcDNA showed only a modest, dose-dependent decline 
in viral budding and infectivity (Fig. 10a, lanes 1′–6′). In 
contrast, beginning at a 5:1 ratio of wt FFV to Src-Gag 
genomes, Gag processing clearly decreased in cell lysates 
and released particles (Fig.  10a, lanes 1–6). Concomi-
tantly, titers drastically declined with a decreasing wt to 
Src-Gag ratio confirming the trans-dominant negative 
effect of Src-Gag variants (Fig.  10b). Infectivity and Gag 
processing were completely abolished when Src-Gag-
encoding proviruses exceeded one-third of the total input.
Comparison to simian foamy virus structure
The structure of the FFV Gag-Env interaction (Fig.  11, 
modelled on the PFV structure [38]) indicates that muta-
tions that affect only budding tend to be located at the 
Gag-Env interface (Gag Q11 and L51). Conversely, muta-
tions which also affect Gag processing and capsid assem-
bly (G36 and R43) localize to the central beta-sheet and 
are therefore likely to affect the folding of the Gag struc-
ture (Fig. 11 and Additional file 3: Table S1). Gag R32 also 
resides in the central beta-sheet but only affects budding, 
indicating that the structural rearrangement here is likely 
to be more subtle. Gag H25A and D53A, which have an 
attenuated or wt phenotype, respectively, also occur in or 
Fig. 8 Gag processing requires both Pol and the viral genome. a Schematic structures of the four FFV genomes mATG, mATG-GC, mΔBBBB-GC and 
EO-GC. b 293T cells were co-transfected in 10 cm dishes with 2 µg of pBC-Gag-oPRE-based Gag constructs (wt, Q11A, H25A, R32A, G36A, R43A or 
L51A), 2 µg pMP-Pol-oPRE and 2 µg of the genome mATG. The viral genome was substituted by pcDNA as a negative control. Cell lysates were ana-
lyzed by SDS-PAGE. Positions of Gag p48 and p52, Pol precursor p127Pol and PR-RT-RN domain p65Pol are marked. c 293T cells were co-transfected in 
10 cm dishes with 2 µg pBC-Gag-oPRE, 2 µg pMP-Pol-oPRE, 2 µg pBC-Env and 2 µg of each of four vector genomes. pcDNA was used as the nega-
tive control. Cell lysates and VLPs in supernatants were analyzed by SDS-PAGE. Positions of Gag p48 and p52, Pol precursor p127Pol and PR-RT-RN 
domain p65Pol are marked. d Viral RNAs in Gag particles were quantified by qRT-PCR. The figure shows an average of two independent experiments, 
with error bars indicating the range. Data is given as the relative number of cDNA copies compared to the RNA packaging-competent vector mATG, 
which was set to a value of 100 %
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near the Gag-Env interface but on Gag loops interacting 
with Env loops, both of which may be flexible (Fig. 11 and 
Additional file 3: Table S1).
Discussion
Here, we present data on the functional importance of 
the N-terminus of FFV Gag for capsid formation, Gag 
Fig. 9 Pol is not incorporated into myr-Gag capsids. a Construction of FFV proviral Src-Gag mutants in the pCF-7 provirus. A myr signal derived 
from the human cellular protein Src was added onto the N-termini of FFV wt Gag and Gag mutants mLQQLY, mHGDII and mPGDRW (shown in Italic 
and bold). b 293T cells were transfected in 10 cm dishes with 8 µg of proviral pCF-7-based wt Gag (lane 1), Gag mutants (mLQQLY, mHGDII, mPG-
DRW, Src-Gag, Src-mLQQLY, Src-mHGDII and Src-mPGDRW) (lanes 2–8), or pcDNA (lane 10). Cell lysates and VLPs in supernatants were analyzed by 
SDS-PAGE. Positions of Gag p48 and p52, Pol precursor p127Pol and PR-RT-RN domain p65Pol are marked. c Intracellular capsid assembly of FFV virus, 
Gag sub-viral particles (SVPs) and Src-Gag SVPs were visualized by transmission electron microscopy of transfected and fixed 293T cells. Transmis-
sion electron micrographs show representative thin sections of the cells. Scale bars are 500 nm in length
Page 13 of 20Liu et al. Retrovirology  (2016) 13:57 
processing, particle budding and infectivity. The data 
confirm and expand the current literature on FV mor-
phology and assembly, based mainly on studies in PFV 
[24, 39]. However, our results also highlight significant 
differences between PFV and FFV. Comparison of PFV 
and non-primate FVs reveals that the N-terminus of 
PFV Gag has seven extra, mostly non-essential residues 
(Fig. 4a). Furthermore, PFV Gag also contains a predicted 
coiled-coil region of up to 130 additional amino acids, a 
feature visible by comparative cryo-electron microscopy 
of FFV and PFV particles [14, 28, 30].
Alanine scanning mutagenesis of FFV Gag residues 
5–9 (LNPLQ) slightly impaired particle release but led 
to a 1000-fold decrease in titer, strongly indicating that 
this region is essential for infection of new host cells but 
not assembly, processing or release. Meanwhile, residues 
10–14 are involved in Gag protein processing, particle 
release and infectivity. Specifically, though the FFV Gag 
L10A mutant was still capable of proper capsid formation 
and infectious particle release, the PFV Gag L17A mutant 
had dramatically reduced viral titers and PFV Gag L17S 
was even unable to release particles [24]. In contrast, a 
mutation of the neighboring residue, FFV Gag Q11A, 
allowed normal Gag processing and capsid assembly, 
but abolished Elp interaction, impacting particle release 
and infectivity, pointing to Q11’s essential function in 
budding.
Alanine mutations of an extended, modestly conserved 
N-terminal region of FFV Gag (residues 15–24, INNGL 
and QPNPG) led to wt phenotypes, despite a substan-
tial increase in hydrophobicity. In PFV Gag, this region 
forms an exposed loop (PFV residues 22–31; Fig.  11 
[38]), and our data suggest that the precise conforma-
tion is not important for function. However, substitution 
of the same 10-mer sequence (INNGLQPNPG) by five, 
eight or ten alanines showed that the latter two substi-
tutions yielded a wt phenotype with a slight reduction 
in titer whereas replacement of the 10-mer sequence 
Fig. 10 Myristoylated Gag interferes with Gag processing and viral titer in a trans-dominant negative fashion. a 293T cells were co-transfected with 
different ratios of the FFV wt genome pCF-7 and the proviral Src Gag clone (lanes 1–6) or the empty vector pcDNA (lanes 1′–6′). Cell lysates and VLPs 
in supernatants were analyzed by SDS-PAGE. FFV Gag p48 and p52 are marked. b Two days p.t., infectivity was determined by titration of culture 
supernatants on FeFab cells. Mean titers of three independent experiments are given. Error bars represent the standard deviation
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Fig. 11 Mutations at the Gag–Elp interface or central beta-sheet affect budding and Gag folding. Modelled structure of the FFV Gag–Elp interac-
tion indicates that mutations affecting only budding tend to localize at the Gag–Elp interface. Mutations which also affect Gag processing and 
capsid assembly localize to the central beta-sheet, therefore likely affecting the overall folding of Gag. The top panel shows a structure of the 
interaction of FFV Gag (cyan ribbon) and Env (yellow ribbon) modelled using the PFV structure [38] as a template (only one dimer of the dimer–dimer 
is shown). The eight 5-mers mutated to alanine are colored by phenotype (white, wild-type; blue, no budding; red, no budding, Gag processing or 
capsid assembly). Side chains of single point mutations in Gag are labelled and shown as sticks colored by atom type (except for glycine C-alpha 
atoms, shown as spheres). Labels are colored by phenotype. Env side chains interacting with Gag are shown as sticks colored by atom type. Image 
was created with PyMOL [http://sourceforge.net/projects/pymol/]. The bottom panel shows protein sequence alignments of FFV and PFV Gag and 
a matrix of. Inter-molecular side-chain interactions indicated with ‘X’. Helical regions identified from the human Gag structure are shown as a black 
bar; beta strands are shown as a black arrow. Sequence numbers refer to the FFV sequence. The 5-mer mutants and the single point mutants are 
colored by phenotype as above (GAG_FFV boxes and dots, respectively). Gag residues playing a role in Gag-Env affinity or particle egress [38, 57] are 
indicated with black dots
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by only five alanines led to wt levels of particle budding 
and Gag processing but a 100-fold decrease in titer (data 
not shown). This indicates that the spacing of critical 
elements is essential for proper conformation and func-
tion of the N-terminus of Gag, at least during target cell 
infection.
Alanine replacements of FFV Gag residues 25–29 
(HGDII) completely blocked budding but did not affect 
capsid formation and Gag processing, suggesting a defect 
in Elp interaction or capsid transfer to the site of bud-
ding. Of the five exchanges, only H25A impaired but not 
complete blocked budding and infectivity, similar to the 
PFV Gag H32 mutant [24]. In contrast, alanine replace-
ment of each of the subsequent 5-mer blocks (AVRFT, 
GGPWG and PGDRW) fully abrogated capsid assembly, 
Gag processing, particle release and infectivity. In PFV 
Gag, this region forms part of a beta-sheet and mutations 
likely lead to aberrant protein folding [24, 32].
Mutation of the highly conserved FFV Gag CTRS resi-
due R43 cripples capsid formation, Gag processing and 
particle release, similar to mutation of PFV Gag residue 
R50 [11, 39]. In contrast, FFV Gag mutant W38A has a 
wt phenotype, while PFV Gag W45A is defective in parti-
cle release and replication.
Particle budding, Elp interaction and infectivity are 
abrogated by FFV Gag mutations Q11A, and L51A 
(Figs.  4, 7) while capsid formation is not affected. The 
structure of the FFV Gag–Elp interaction (Fig. 11, mod-
elled on the PFV structure [38]) indicates that mutations 
affecting only budding (Q11A, H25A, and L51A, Figs. 4 
and 7) tend to localize to the Gag–Elp interface, imply-
ing that accessibility of these residues is required for 
Gag–Elp interaction. In contrast, mutations also affect-
ing capsid assembly and Gag processing (G36 and R43) 
may hinder folding of the central beta-sheet and distort 
the overall structure. Gag assembly therefore mainly 
requires a defined structure and proper folding of the 
Gag N-terminus.
The current study also explores the sub-cellular site 
of capsid assembly and RNA and Pol packaging. Three 
important features were observed when targeting FFV 
capsid assembly to intracellular membranes and the 
plasma membrane using myr signals. Firstly, low-level 
budding of unprocessed Gag was observed, even by the 
assembly-deficient Gag CTRS mutant mPGDRW, simi-
lar to PFV [11]. This indicates that membrane targeting 
can at least partially overcome a budding defect or that 
Gag contains additional domains important for assembly. 
Secondly, retargeted FFV Gag exhibited a nearly com-
plete absence of cell-associated processing, even in the 
presence of the wt virus. Under similar conditions, PFV 
was still capable of reduced levels of Gag processing [11]. 
Thirdly, co-transfection of wt and myr-Gag proviruses 
showed that the myr signal was clearly trans-dominant 
over the N-terminal MTOC-targeting region in Gag 
(Fig. 10).
RNA packaging and concomitant Pol incorporation 
likely occur in the cytoplasm around the MTOC [40]. 
Thus, assembly site retargeting to membranes via a myr 
signal may yield empty viral cores lacking genomes or 
Pol since capsids do no longer co-localize with the viral 
genome and Pol detectable by the inability of these 
mutants to process Gag. C-terminal cleavage of wt FFV 
Gag was dramatically suppressed by myr-Gag, even at a 
wt:myr-Gag ratio of 5:1. Alternatively, the aberrant cap-
sid structures seen in TEM images (Fig. 9c) may not allow 
genome and Pol packaging, again leading to a defect in 
Gag processing.
Importantly, our data show a clear correlation between 
FV capsid assembly and Gag processing (see Additional 
file  3: Table S1), potentially homologous to budding-
induced Gag and Gag-Pol processing of orthoretrovi-
ruses [1]. The data for FFV provided here show a clear 
correlation between defects in cytosolic capsid assembly 
and the absence of terminal Gag processing in mutants 
mAVRFT, mGGPWG, mPGDRWT, G36A and R43A. 
Cartellieri et  al. [39] detected wt intracellular Gag pro-
cessing by the assembly-deficient PFV R50A mutant. In 
contrast, Eastman and Linial [11] reported reduced Gag 
processing by PFV R50A and R50 W mutants, similar to 
our results with the corresponding FFV Gag mutant.
In addition to assembly-competent Gag and the full-
length FFV Pol precursor, Gag processing also requires 
FFV genome packaging into virus particles (Fig. 8). While 
a packaging-competent proviral genome is absolutely 
required, the Env-encoded particle budding machinery 
is fully dispensable. This finding fits well into the cur-
rent model of FV Pol incorporation, where viral RNA 
genome encapsidation during or after cytosolic capsid 
assembly also mediates Pol packaging via binding to the 
Pol encapsidation signal on the genome [10, 21]. Remi-
niscent to MTOC targeting of Gag for capsid assembly in 
FVs and B/D type retroviruses, genomic RNA of Mason-
Pfizer monkey virus, which also assembles at the MTOC, 
is directed to the site of assembly by microtubule bind-
ing [41]. Conversely, HIV genomes are evenly distributed 
throughout the cell, allowing genome packaging at the 
plasma membrane, the site of assembly [41]. It is cur-
rently unknown but likely that FV genomes are also tar-
geted to the MTOC for efficient genome encapsidation.
While FV Gag processing depends on capsid formation 
but is clearly budding-independent as shown in Fig.  8, 
this is not the case for FV Pol auto-processing. FV Pol is 
expressed independently of Gag via a spliced transcript 
and undergoes fundamentally different activation mech-
anisms compared to orthoretroviruses [18, 42, 43]. As 
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shown here for FFV and previously for PFV, Pol under-
goes auto-processing independent of co-expressed Gag, 
though part of the pol transcript may be essential for PR 
dimerization and processing [19, 43].
Using Pol packaging and terminal Gag cleavage as 
surrogate markers for genomic RNA incorporation, the 
mutations introduced at the 5′-end of the gag gene did 
not affect the 5′ genomic RNA encapsidation signal, as 
released particles contained processed Pol and cleaved 
Gag (Figs. 2b, 4b, 8). Though PFV Pol is freely released 
from cells [44], our data show that FFV Pol is released 
only in budded particles (Fig.  8). Previous studies sug-
gest that PFV Gag GR box  1 mutants, which package 
genomes into particles, do not encapsidate Pol, likely 
due to abrogation of essential Gag-Pol interactions, 
indicating that genome binding to Pol is insufficient 
[45].
In summary, our study identifies specific residues in 
FFV Gag essential for capsid assembly and Elp interac-
tion. We found a clear correlation between FV capsid 
assembly and Gag processing, homologous to budding-
induced Gag and Gag-Pol processing observed in 
orthoretroviruses. Finally, genome-dependent incorpora-
tion of Pol into capsids appears to be dependent on the 
site of assembly and is a prerequisite for Gag process-
ing. Our data indicate a central role of the N-terminus of 
Gag in at least three completely different functions: FV 
assembly, maturation and budding. The data show that 
FV Gag processing occurs independent of particle bud-
ding, a mechanism distinct from that used by most other 
retroviruses.
Conclusions
Foamy viruses have developed a unique replication strat-
egy combining the classical type B/D retroviral capsid 
assembly pathway and an FV-specific Env-dependent 
particle budding process. The determinants of foamy 
virus (FV) Gag essential for interaction with the Env 
leader protein Elp, a stable and particle-associated N-ter-
minal Env-derived protein, and the multiple functions of 
the N-terminal region of prototype/primate FV (PFV) 
Gag during viral assembly and budding still remain 
poorly understood. Here, we show that residues essential 
for interaction with Elp, particle budding, and release are 
located in the N-terminus of Gag. Distinct, more cen-
trally positioned residues within the cytoplasmic target-
ing-retention signal are essential for capsid formation, as 
determined by sedimentation assays. Furthermore, we 
found that genomic FFV RNA packaging is essential for 
Gag processing by the Pol-encoded protease PR. These 
findings provide new insights into the functional interac-
tion and coordination of different FV structural compo-
nents during assembly in the FV life cycle.
Methods
Cell culture, DNA transfection and indirect 
immunofluorescence
FeFab (created in our lab using Crandell feline kidney 
cells, CrFK, ATCC, Manassa, USA; see [46]), Hela and 
293T (both from ATCC) cells were grown in Dulbecco’s 
modified Eagle’s medium (Sigma-Aldrich) supplemented 
with 10 % fetal calf serum (PAN Biotech) and 1 % peni-
cillin–streptomycin (Sigma-Aldrich), respectively [32, 
46, 47]. Cell identity and absence of contaminants was 
confirmed by multiplex PCR-based cell typing and patho-
gen detection performed by Multiplexion, Heidelberg. 
Transfection of sub-confluent 293T cells with plasmid 
DNA was performed by calcium co–precipitation on 
in 6 or 10  cm dishes as described previously [48]. Cells 
and cell culture supernatants were harvested two d p.t. 
Indirect immunofluorescence of paraformaldehyde-fixed 
transfected HeLa cells allowing a much better analysis of 
subcellular localization than the 293T cells using the FFV 
Gag MA antiserum was done as previously described 
[32].
Titration of FFV and FFV‑related viral vectors using FeFab 
cells
FeFab cells [46] were seeded in 96-well plates (3  ×  104 
cells in 100 μl culture medium per well). Four hours (h) 
post-seeding, supernatants containing wild-type (wt) 
FFV or FFV variants were cleared by centrifugation at 
405×g for 5 min at room temperature. Supernatants were 
serially diluted five-fold by mixing 25 μl viral supernatant 
into the first well then transferring 25  μl diluted super-
natant into subsequent wells. Each sample was titrated 
in duplicate. At 48 h post-infection (p.i.), cells were fixed 
and stained as described previously [46]. Titers were cal-
culated by multiplying the number of blue-stained nuclei 
multiplied by the highest dilution factor.
Purification of FFV particles and virus‑like particles (VLPs)
Cell culture supernatants (5  ml) of transfected 293T 
cells were cleared of cellular debris by centrifugation 
(10  min, 405×g). FFV particles or VLPs were pelleted 
through a 2 ml cushion of 20 % sucrose in PBS (w/v) by 
ultracentrifugation in a SW41Ti rotor (Beckman Coulter, 
Krefeld, Germany) (2  h, 100,000×g, 4  °C). The invisible 
pellet, devoid of medium and sucrose, was re-suspended 
in 50 μl of 1 % SDS in PBS containing complete protease 
inhibitor cocktail (Roche) and stored at −20  °C before 
immunoblotting.
Sucrose gradient sedimentation analysis of intracellular 
capsids
Sucrose gradient centrifugation of intracellular capsids 
was performed with modifications to a method described 
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previously [11]. Transfection of 293T cells was per-
formed in 10 cm dishes. At 36 h p.t., cells were washed 
three times with ice-cold PBS and scraped using a rub-
ber policeman. Cells detached as thin white sheets were 
transferred into 15 ml conical tubes. Cells were pelleted 
by centrifugation (5  min, 405×g). Pellets were resus-
pended in 0.5 ml lysis buffer (10 mM Tris–HCl, pH 7.4, 
5 mM MgCl2, 100 mM KCl, 2 mM dithiothreitol, EDTA-
free complete protease inhibitor cocktail) without Tri-
ton X-100 and transferred into 1.5  ml Eppendorf tubes. 
An equal volume of lysis buffer with 0.2 % Triton X-100 
was added to each tube and mixed gently. Pellets were 
homogenized by shearing five times with an ice-cold 
26-gauge syringe cleared of air bubbles. After shearing, 
the cell pellet was left on ice for 10 min, then sedimented 
for 10 min at 4 °C at 1300×g in a pre-cooled Eppendorf 
centrifuge. Supernatants of cytoplasmic extracts contain-
ing the particles were carefully loaded onto a preformed 
and stepwise sucrose gradient consisting of 600 μl of 10, 
20, 30, 40, 50, and 60 % sucrose in 1× PBS equilibrated 
overnight. Gradients were centrifuged in a SW60Ti 
rotor (Beckman Coulter, 1 h, 35,000 rpm, 4 °C). Particles 
migrate through the gradient corresponding to their sedi-
mentation behavior. A total of six fractions (700 μl each) 
were collected from the top of the gradient using a 1 ml 
micropipette and stored at −70  °C before analysis by 
immunoblotting.
Molecular cloning of FFV constructs
FFV vector pCF-7-ubi-lacZ-mATG (mATG), contain-
ing an inactivated gag ATG, and the RNA-packaging 
deficient vectors pCF-7-ubi-lacZ-mATG-GC (mATG-
GC), pCF-7-ubi-lacZ-mΔBBBB-GC (mΔBBBB-GC) and 
pCF-EO-GC (EO-GC) were recently described [35]. 
pMP-Pol-oPRE was used for FFV Pol expression. The 
cytomegalovirus immediate-early promoter-based Gag 
expression clone pBC-Gag-oPRE and the infectious FFV 
molecular clone pCF-7 were used as cloning backbones 
[35, 49].
PCR-mediated mutagenesis was used to introduce dif-
ferent small N-terminal Gag deletions into pCF-7. PCR 
sense primers E4AΔ5, E4AΔ7, E4AΔ9, E4AΔ11 and 
antisense primer AS (Additional file  4: Table S2) were 
used. The amplicons were digested with XhoI and BlpI 
and inserted into the correspondingly digested pCF-7. 
The new constructs are designated E4AΔ5, E4AΔ5-7, 
E4AΔ5-9 and E4AΔ5-11, respectively.
Alanine scanning mutagenesis was performed via 
fusion PCR [50] to systematically replace blocks or 
defined N-terminal residues by alanines (A). The Gag 
constructs and corresponding primers are designated 
with the residue(s) substituted by alanine(s), For example, 
mLNPLQ indicates a replacement of the LNPLQ motif 
by 5 alanines. Likewise, R43A indicates a replacement of 
FFV Gag arginine-43 by alanine (Additional file 4: Table 
S2). Corresponding regions of each gene were amplified 
by PCR. For example, to clone mutant Gag mLNPLQ, 
the upstream fragment was amplified using primers 
dLNPLQ-1s and dLNPLQ-1as; the downstream fragment 
was amplified using primers dLNPLQ-2s and dLNPLQ-
2as (Additional file 4: Table S2). Both PCR products were 
fused in a third PCR using primers Gag mut-1s and Gag 
mut-2as. The resulting amplicons were cloned into pCF-7 
or pBC-Gag-oPRE using XhoI and SmaI.
To create proviral myr-Gag mutants, the nine-amino 
acid src signal sequence was engineered onto the N-ter-
minus of wt or mutant Gag (mLQQLY, mHGDII, mPG-
DRW) in pCF-7. The complementary oligonucleotides 
Src(+) and Src(−), containing the src signal (Additional 
file 4: Table S2), were annealed, generating SwaI and XhoI 
overhangs. The annealed oligonucleotides were cloned 
into pCF-7 using SwaI and XhoI, generating the corre-
sponding mutants Src-Gag, Src-mLQQLY, Src-mHGDII 
and Src-mPGDRW, respectively.
Expression of his‑tagged FFV Elp in Escherichia coli BL21
The FFV N-terminal leader protein Elp was recom-
binantly produced in E. coli BL21 as an N-terminal 
His-tag fusion protein [14]. Pre-cultures of 200  ml LB 
medium containing 50 µg/ml ampicillin were inoculated 
from glycerol stocks of E. coli BL21 transformed with the 
pET32a(+)-His-Elp expression plasmid and grown at 
37  °C and 200  rpm overnight. Overnight cultures were 
used to inoculate 1  l of LB medium containing 50  µg/
ml ampicillin in a 5 l flask. Cultures were grown at room 
temperature under shaking conditions till an OD600 
of 0.6. Expression of His-tagged fusion proteins was 
induced by the addition of IPTG at a final concentration 
of 250 μM. Protein expression cultures were grown for a 
further 6 h under the same conditions before harvesting 
at 8000 rpm and 4 °C for 10 min in a Beckmann Sorvall 
centrifuge using the SLA300 rotor. Pellets were resus-
pended in 5 ml 1× PBS supplemented with 1× protease 
inhibitor and 2 mM DTT and stored at −20 °C. To pre-
pare cleared His-Elp lysates under native conditions, E. 
coli pellets were thawed on ice for 15 min and disrupted 
by passing the cell suspension three times through an 
Emulsiflex C5 French press (AVESTIN) at 1000–1500 
bars. Cell lysates were cleared at 10,000×g for 30 min at 
4  °C. Cleared supernatants containing the soluble pro-
teins were stored on ice for pull-down assays.
Immunoblot analyses
Transfected 293T cells in 10  cm dishes were harvested 
2  days p.t. and lysed in 1  % SDS. Immunoblotting was 
performed as previously described [30]. Expression of 
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Gag, Env and Pol in cell lysates and released particles were 
visualized using guinea pig polyclonal serum against the 
capsid CA domain of FFV Gag (α-FFV CA, 1:2000) [51], 
goat polyclonal serum against the TM domain of FFV 
Env (α-FFV TM, 1:1000 dilution) and rabbit polyclonal 
serum against the protease domain of FFV Pol (α-FFV 
PR’ 1:3000) in 5 % milk powder in PBS containing 0.1 % 
Tween-20. After incubation with secondary antibody 
conjugated with horse radish peroxidase (HRP, 1:5000), 
the membranes were developed using ECL™ western 
blotting detection reagents (GE Healthcare). Amersham 
Hyperfilm™ ECL films (GE Healthcare) were exposed to 
the resulting chemiluminescence signals for 5 s to 3 min 
before development in an AGFA film processor.
Pull‑down assay
Transfected 293T cells in 10  cm dishes were harvested 
2  days p.t. Cells were washed once with 1×  PBS and 
lysed in cold 600 μl Triton lysis buffer (TLB, 20 mM Tris, 
137  mM NaCl, 10  % glycerol, 100  mM KCl, 1  % Triton 
X-100, pH 7.4) supplemented with 1×  EDTA-free pro-
tease inhibitor and transferred to a sterile 1.5 ml Eppen-
dorf tube as described previously [52]. Cells were lysed at 
4 °C for 1 h in an overhead shaker. Meanwhile, Ni–NTA 
agarose (Qiagen) was prepared by transferring 100 μl of 
Ni–NTA slurry (50 μl bed volume) to a 1.5 ml Eppendorf 
tube and washing three times with 1  ml cold PBS and 
twice with 1 ml TLB.
Equilibrated Ni–NTA agarose were carefully sedi-
mented after centrifugation for 10  min at 500×g and 
mixed with 1  ml cleared E. coli lysates containing 
His-tagged recombinant proteins on a rotary shaker 
(200 rpm, 4 °C, 60 min). Escherichia coli lysate-Ni–NTA 
mixtures were sedimented to remove the supernatant and 
washed three times in cold PBS for 10 min at 400×g. Cell 
lysates (500 μl) were added to the mixture and shaken on 
a rotary shaker (200  rpm, 4  °C, 60  min). After washing 
three times in cold TLB for 10 min at 400×g, His-tagged 
Elp was eluted from the Ni–NTA agarose by adding 
60 μl 1 % SDS and boiling the samples at 95 °C for 5 min. 
Ni–NTA agarose was sedimented by centrifugation for 
10 min at 15,000 rpm. Supernatants were transferred to 
a new 1.5 ml Eppendorf tube. Aliquots of cell lysates and 
eluates were analyzed by SDS-PAGE and immunoblot-
ting. Elp-His was detected with a polyclonal antibody 
against the His-tag (Abcam). FFV Gag was detected with 
an α-FFV CA polyclonal serum (described above).
Transmission electron microscopy analysis
For transmission electron microscopy (TEM) 293T cells 
were transfected in 6  cm dishes with 6  μg of plasmid 
DNA. At 2  days p.t., cells with a transfection efficiency 
greater than 60  % were washed three times and fixed 
in situ with 2.5 % glutaraldehyde in 50 mM sodium caco-
dylate (pH 7.6) for 30  min at 4  °C before processing as 
described previously [53].
Genomic RNA extraction from viral particles and qRT‑PCR
Genomic RNA in viral particles was extracted using 
Trizol® (Invitrogen) according to the manufacturer’s 
instructions. RNA was incubated with 2 U of RNase-free 
DNase I (New England Biolabs). RNA was converted 
to cDNA using the QuantiTect Reverse Transcription 
Kit (Qiagen) using the cDNA synthesis primer 5′-GTA 
GGTGTGCGGTAGGCTTT-3′. qPCR of a ubiquitinC 
promoter fragment encoded by the vector genomes was 
performed using SYBR Green and the cDNA synthesis 
primer and sense-primer 5′-CTGACGCCTCACTTAT 
CCCT-3′ as described previously [35]. cDNA was used 
for quantitative RT-PCR analysis.
Modelling of Gag‑Env interaction structure
The structure of the interaction between foamy virus 
GAG and ENV was modelled using Modeller [54] with the 
human structure [PDB 4jmr, 38] as a template. Contacts 
between side-chains were identified using RasMol [55].
Abbreviations
BFV: bovine foamy virus; CC: coiled-coil; CTRS: cytoplasmic targeting and 
retention signal; EFV: equine foamy virus; Elp: Env leader protein; FFV: feline 
foamy virus; FV: foamy virus; HIV: human immunodeficiency virus; IN: integrase; 
Additional files
Additional file 1: Figure S1. Defined alanine substitution mutations of 
N-terminal Gag sequence inhibit syncytia formation in transfected 293T 
cells. 293T cells were transfected in 6 cm dishes with 6 μg of plasmids 
expressing proviral Gag mutants (mLNPLQ, mLQQLY, mINNGL, mQPNPG, 
mHGDII, mAVRFT, mGGPWG and mPGDRW, panel A) or (Q11A, H25A, 
R32A, G36A, W38A, G39A, R43A, L51A, D53A, panel B), pCF-7, or pCDNA 
using calcium phosphate. Transfection efficiency was monitored by co-
transfection of 1 μg pGfp. At 12 hrs p.t., cells were visualized by Gfp auto-
fluorescence. Bright GFP-positive individual cells as well as large areas 
representing fused neighboring cells transfected by fusion-competent 
mutants are detectable.
Additional file 2: Figure S2. Subcellular localization of five alanine scan-
ning Gag mutants. Hela cells were transfected with proviral pCF-7-based 
Gag mutants (mLNPLQ, mLQQLY, mINNGL, mQPNPG, mHGDII, mAVRFT, 
mGGPWG, or mPGDRW) or the parental provirus pCF-7. pcDNA plasmid 
was used for transfection as negative control. Thirty-six hours post-trans-
fection, cells were fixed and stained with a rabbit polyclonal antiserum 
generated against FFV Gag and Alexa-488-conjugated secondary anti-
body. Nuclei were stained with DAPI. Scale bars are 50 µm in length.
Additional file 3: Table S1. Summary of single amino acid mutagenesis 
of defined N-terminal FFV Gag residues. Comparative characterization of 
wt and Gag mutant FFV proviruses with respect to FFV infectivity, particle 
formation and budding, Elp interaction, Gag processing and syncytia 
formation. Phenotypes are characterized as +++: like wt; +: strongly 
reduced; - negative/absent.
Additional file 4: Table S2. Primers used for cloning and site-directed 
mutagenesis. Underlined characters indicate a SwaI single-stranded 
overhang. Bold text indicates an XhoI restriction site.
Page 19 of 20Liu et al. Retrovirology  (2016) 13:57 
MTOC: microtubule organizing center; PFV: prototype/primate foamy virus; 
p.t.: post-transfection; wt: wild-type.
Authors’ contributions
YL, JL, TK, GW, and ML conceived and designed the experiments. YL, QB, 
and GW performed the mutagenesis, expression, and infection studies. MJB 
performed the Gag modelling and analysis. YL, MJB, RBR, TK, and ML analyzed 
the data. YL, MJB, JL, and ML prepared the manuscript. All authors read and 
approved the final manuscript.
Author details
1 Department of Molecular Diagnostics of Oncogenic Infections, Research 
Program Infection and Cancer, German Cancer Research Center (DKFZ), Im 
Neuenheimer Feld 242, 69120 Heidelberg, Germany. 2 CellNetworks, Bioquant, 
University of Heidelberg, Im Neuenheimer Feld 267, 69120 Heidelberg, 
Germany. 3 Biochemie Zentrum Heidelberg (BZH), Im Neuenheimer Feld 328, 
69120 Heidelberg, Germany. 4 Present Address: Center for Cancer Research, 
National Cancer Institute, Frederick, MD, USA. 5 Present Address: Department 
of Oncology, University of Oxford, Oxford, UK. 6 Present Address: Biology 
Department, East China Normal University, Shanghai, China. 
Acknowledgements
We thank Birgit Hub for excellent support in electron microscopy and Lutz 
Gissmann (both German Cancer Research Center) for continuous support and 
interest in our studies.
Competing interests
The authors declare that they have no competing interests.
Funding
This work was funded in part by the German Cancer Research Center, 
Heidelberg, Germany. YL, GW, and QB are supported by PhD stipends from 
the Chinese Scholarship Council. JL is supported by a PhD stipend from the 
Helmholtz International Graduate School for Cancer Research. The funders 
had no role in study design, data collection and analysis, decision to publish, 
or preparation of the manuscript.
Received: 17 June 2016   Accepted: 4 August 2016
References
 1. Sundquist WI, Kräusslich H-G. HIV-1 assembly, budding, and maturation. 
Cold Spring Harb Perspect Med. 2012;2:a006924.
 2. Freed EO. HIV-1 assembly, release and maturation. Nat Rev Microbiol. 
2015;13:484–96.
 3. Suomalainen M, Hultenby K, Garoff H. Targeting of Moloney murine 
leukemia virus gag precursor to the site of virus budding. J Cell Biol. 
1996;135:1841–52.
 4. Vogt PK, Friis RR. An avian leukosis virus related to RSV(O): properties and 
evidence for helper activity. Virology. 1971;43:223–34.
 5. Weiss ER, Göttlinger H. The role of cellular factors in promoting HIV bud-
ding. J Mol Biol. 2011;410:525–33.
 6. Choi G, Park S, Choi B, Hong S, Lee J, Hunter E, et al. Identification of a 
cytoplasmic targeting/retention signal in a retroviral Gag polyprotein. J 
Virol. 1999;73:5431–7.
 7. Sfakianos JN, LaCasse RA, Hunter E. The M-PMV cytoplasmic targeting-
retention signal directs nascent Gag polypeptides to a pericentriolar 
region of the cell. Traffic. 2003;4:660–70.
 8. Stansell E, Apkarian R, Haubova S, Diehl WE, Tytler EM, Hunter E. Basic 
residues in the Mason-Pfizer monkey virus gag matrix domain regulate 
intracellular trafficking and capsid-membrane interactions. J Virol. 
2007;81:8977–88.
 9. Hütter S, Zurnic I, Lindemann D. Foamy virus budding and release. 
Viruses. 2013;5:1075–98.
 10. Lindemann D, Rethwilm A. Foamy virus biology and its application for 
vector development. Viruses. 2011;3:561–85.
 11. Eastman SW, Linial ML. Identification of a conserved residue of 
foamy virus Gag required for intracellular capsid assembly. J Virol. 
2001;75:6857–64.
 12. Yu SF, Eastman SW, Linial ML. Foamy virus capsid assembly occurs at a 
pericentriolar region through a cytoplasmic targeting/retention signal in 
Gag. Traffic. 2006;7:966–77.
 13. Lindemann D, Pietschmann T, Picard-Maureau M, Berg A, Heinkelein M, 
Thurow J, et al. A particle-associated glycoprotein signal peptide essential 
for virus maturation and infectivity. J Virol. 2001;75:5762–71.
 14. Wilk T, Geiselhart V, Frech M, Fuller SD, Flügel RM, Löchelt M. Specific 
interaction of a novel foamy virus Env leader protein with the N-terminal 
Gag domain. J Virol. 2001;75:7995–8007.
 15. Flügel RM, Pfrepper KI. Proteolytic processing of foamy virus Gag and Pol 
proteins. Curr Top Microbiol Immunol. 2003;277:63–88.
 16. Geiselhart V, Schwantes A, Bastone P, Frech M, Löchelt M. Features of the 
Env leader protein and the N-terminal Gag domain of feline foamy virus 
important for virus morphogenesis. Virology. 2003;310:235–44.
 17. Geiselhart V, Bastone P, Kempf T, Schnölzer M, Löchelt M. Furin-
mediated cleavage of the feline foamy virus Env leader protein. J Virol. 
2004;78:13573–81.
 18. Yu SF, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML. Human foamy virus 
replication: a pathway distinct from that of retroviruses and hepadnavi-
ruses. Science. 1996;271:1579–82.
 19. Löchelt M, Flügel RM. The human foamy virus pol gene is expressed 
as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol. 
1996;70:1033–40.
 20. Spannaus R, Hartl MJ, Wöhrl BM, Rethwilm A, Bodem J. The prototype 
foamy virus protease is active independently of the integrase domain. 
Retrovirology. 2012;9:41.
 21. Peters K, Wiktorowicz T, Heinkelein M, Rethwilm A. RNA and protein 
requirements for incorporation of the Pol protein into foamy virus parti-
cles. J Virol. 2005;79:7005–13.
 22. Heinkelein M, Leurs C, Rammling M, Peters K, Hanenberg H, Rethwilm A. 
Pregenomic RNA is required for efficient incorporation of pol polyprotein 
into foamy virus capsids. J Virol. 2002;76:10069–73.
 23. Life RB, Lee E-G, Eastman SW, Linial ML. Mutations in the amino terminus 
of foamy virus Gag disrupt morphology and infectivity but do not target 
assembly. J Virol. 2008;82:6109–19.
 24. Reh J, Stange A, Götz A, Rönitz M, Große A, Lindemann D. An N-terminal 
domain helical motif of prototype foamy virus gag with dual functions 
essential for particle egress and viral infectivity. Retrovirology. 2013;10:45.
 25. Tobaly-Tapiero J, Bittoun P, Giron ML, Neves M, Koken M, Saïb A, et al. 
Human foamy virus capsid formation requires an interaction domain in 
the N terminus of Gag. J Virol. 2001;75:4367–75.
 26. Petit C, Giron M-L, Tobaly-Tapiero J, Bittoun P, Real E, Jacob Y, et al. 
Targeting of incoming retroviral Gag to the centrosome involves a direct 
interaction with the dynein light chain 8. J Cell Sci. 2003;116:3433–42.
 27. Hamann MV, Müllers E, Reh J, Stanke N, Effantin G, Weissenhorn W, et al. 
The cooperative function of arginine residues in the prototype foamy 
virus Gag C-terminus mediates viral and cellular RNA encapsidation. 
Retrovirology. 2014;11:87.
 28. Müllers E, Uhlig T, Stirnnagel K, Fiebig U, Zentgraf H, Lindemann D. 
Novel functions of prototype foamy virus Gag glycine- arginine-rich 
boxes in reverse transcription and particle morphogenesis. J Virol. 
2011;85:1452–63.
 29. Müllers E, Stirnnagel K, Kaulfuss S, Lindemann D. Prototype foamy virus 
gag nuclear localization: a novel pathway among retroviruses. J Virol. 
2011;85:9276–85.
 30. Winkler I, Bodem J, Haas L, Zemba M, Delius H, Flower R, et al. Charac-
terization of the genome of feline foamy virus and its proteins shows 
distinct features different from those of primate spumaviruses. J Virol. 
1997;71:6727–41.
 31. Kehl T, Tan J, Materniak M. Non-simian foamy viruses: molecular virology, 
tropism and prevalence and zoonotic/interspecies transmission. Viruses. 
2013;5:2169–209.
 32. Liu Y, Kim Y-B, Löchelt M. N-terminally myristoylated feline foamy virus 
Gag allows Env-independent budding of sub-viral particles. Viruses. 
2011;3:2223–37.
Page 20 of 20Liu et al. Retrovirology  (2016) 13:57 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 33. Bleiholder A. Evaluation of the feline foamy virus envelope glycoprotein 
as scaffold for the presentation of epitope sequences targeted by the 
HIV-1 broadly neutralizing antibodies 2F5 and 4E10. Ruprect-Karls-Univer-
sität Heidelberg; 2012.
 34. Shaw KL, Lindemann D, Mulligan MJ, Goepfert PA. Foamy virus envelope 
glycoprotein is sufficient for particle budding and release. J Virol. 
2003;77:2338–48.
 35. Liu W, Backes P, Löchelt M. Importance of the major splice donor and 
redefinition of cis-acting sequences of gutless feline foamy virus vectors. 
Virology. 2009;394:208–17.
 36. Liu W, Lei J, Liu Y, Lukic DS, Räthe A-M, Bao Q, et al. Feline foamy virus-
based vectors: advantages of an authentic animal model. Viruses. 
2013;5:1702–18.
 37. Zhadina M, McClure MO, Johnson MC, Bieniasz PD. Ubiquitin-dependent 
virus particle budding without viral protein ubiquitination. Proc Natl Acad 
Sci USA. 2007;104:20031–6.
 38. Goldstone DC, Flower TG, Ball NJ, Sanz-Ramos M, Yap MW, Ogrodowicz 
RW, et al. A unique spumavirus Gag N-terminal domain with func-
tional properties of orthoretroviral matrix and capsid. PLoS Pathog. 
2013;9:e1003376.
 39. Cartellieri M, Herchenröder O, Rudolph W, Heinkelein M, Lindemann D, 
Zentgraf H, et al. N-terminal Gag domain required for foamy virus particle 
assembly and export. J Virol. 2005;79:12464–76.
 40. Heinkelein M, Dressler M, Jármy G, Rammling M, Imrich H, Thurow J, et al. 
Improved primate foamy virus vectors and packaging constructs. J Virol. 
2002;76:3774–83.
 41. Pocock GM, Becker JT, Swanson CM, Ahlquist P, Sherer NM. HIV-1 and 
M-PMV RNA nuclear export elements program viral genomes for distinct 
cytoplasmic trafficking behaviors. PLoS Pathog. 2016;12:e1005565.
 42. Bodem J, Löchelt M, Delius H, Flügel RM. Detection of subgenomic 
cDNAs and mapping of feline foamy virus mRNAs reveals complex pat-
terns of transcription. Virology. 1998;244:417–26.
 43. Hartl MJ, Bodem J, Jochheim F, Rethwilm A, Rösch P, Wöhrl BM. Regula-
tion of foamy virus protease activity by viral RNA: a novel and unique 
mechanism among retroviruses. J Virol. 2011;85:4462–9.
 44. Swiersy A, Wiek C, Reh J, Zentgraf H, Lindemann D. Orthoretroviral-like 
prototype foamy virus Gag-Pol expression is compatible with viral repli-
cation. Retrovirology. 2011;8:66.
 45. Lee E-G, Linial ML. The C terminus of foamy retrovirus Gag contains 
determinants for encapsidation of Pol protein into virions. J Virol. 
2008;82:10803–10.
 46. Zemba M, Alke A, Bodem J, Winkler IG, Flower RL, Pfrepper K, et al. 
Construction of infectious feline foamy virus genomes: cat antisera do 
not cross-neutralize feline foamy virus chimera with serotype-specific Env 
sequences. Virology. 2000;266:150–6.
 47. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of 
mutation in human cells by using an Epstein-Barr virus shuttle system. 
Mol Cell Biol. 1987;7:379–87.
 48. Wagner A, Doerks A, Aboud M, Alonso A, Tokino T, Flügel RM, et al. Induc-
tion of cellular genes is mediated by the Bel1 transactivator in foamy 
virus-infected human cells. J Virol. 2000;74:4441–7.
 49. Schwantes A, Ortlepp I, Löchelt M. Construction and functional 
characterization of feline foamy virus-based retroviral vectors. Virology. 
2002;301:53–63.
 50. Yon J, Fried M. Precise gene fusion by PCR. Nucleic Acids Res. 1989;17:4895.
 51. Alke A, Schwantes A, Kido K, Flötenmeyer M, Flügel RM, Löchelt M. The 
bet gene of feline foamy virus is required for virus replication. Virology. 
2001;287:310–20.
 52. Lukic DS, Hotz-Wagenblatt A, Lei J, Räthe A-M, Mühle M, Denner J, et al. 
Identification of the feline foamy virus Bet domain essential for APOBEC3 
counteraction. Retrovirology. 2013;10:76.
 53. Kräusslich HG, Fäcke M, Heuser AM, Konvalinka J, Zentgraf H. The spacer 
peptide between human immunodeficiency virus capsid and nucleocap-
sid proteins is essential for ordered assembly and viral infectivity. J Virol. 
1995;69:3407–19.
 54. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen 
M-Y, et al. Comparative protein structure modeling using Modeller. Curr. 
Protoc. Bioinformatics. 2006; Chapter 5: Unit 5.6.
 55. Sayle R, Milner-White EJ. RASMOL: biomolecular graphics for all. Trends 
Biochem. Sci. Elsevier Current Trends; 1995;20:374–6.
 56. Katzourakis A, Gifford RJ, Tristem M, Gilbert MTP, Pybus OG. Macroevolu-
tion of complex retroviruses. Science. 2009;325:1512.
 57. Stirnnagel K, Lüftenegger D, Stange A, Swiersy A, Müllers E, Reh J, et al. 
Analysis of prototype foamy virus particle-host cell interaction with 
autofluorescent retroviral particles. Retrovirology. 2010;7:45.
